Form 8-K - Current report:
SEC Accession No. 0000950123-07-014400
Filing Date
2007-10-29
Accepted
2007-10-29 17:14:42
Documents
7
Period of Report
2007-10-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y41465e8vk.htm 8-K 17812
2 EX-99.1: PRESS RELEASE DATED OCTOBER 25, 2007 y41465exv99w1.htm EX-99.1 64263
3 EX-99.2: TEXTUAL REPRESENTATION OF CERTAIN PORTIONS OF THE WEBCAST CONFERENCE CA y41465exv99w2.htm EX-99.2 17227
4 EX-99.3: PRESS RELEASE DATED OCTOBER 23, 2007 y41465exv99w3.htm EX-99.3 12057
5 EX-99.4: PRESS RELEASE DATED OCTOBER 22, 2007 y41465exv99w4.htm EX-99.4 19074
6 GRAPHIC y41465y4146500.gif GRAPHIC 4056
7 GRAPHIC y41465y4146501.gif GRAPHIC 1632
  Complete submission text file 0000950123-07-014400.txt   140208
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 071197172
SIC: 2835 In Vitro & In Vivo Diagnostic Substances